Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T33275
(Former ID: TTDI01683)
|
|||||
Target Name |
Tuftsin receptor (TR)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Diagnostic imaging [ICD-11: N.A.] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | 99mTc-RP-128 | Drug Info | Phase 2 | Diagnostic imaging | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | 99mTc-RP-128 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting. | |||||
REF 2 | Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results. J Nucl Med. 2001 Jan;42(1):154-61. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.